-transparent.png){kind=logo}
Increased plasma lipoprotein (a) (Lp(a)) levels are strongly associated with premature cardiovascular disease and stroke. Recently we, as well as other groups, found that apolipoprotein (a) (apo(a)) fragments appear in the urine of healthy individuals, and that renal transplant patients with impaired renal function excrete fewer apo(a) fragments into their urine compared with controls. As the excretion mode of apo(a) is presently unknown, we determined plasma Lp(a) levels and urinary apo(a) excretion in relation to kidney function in 58 proteinuric patients and 58 healthy controls. For the first time, urinary apo(a) excretion was related to apo(a) isoforms. Plasma Lp(a) values were higher in the proteinuric patients compared with the controls, independent of their renal function. The patients with low-molecular-weight apo(a) isoforms had higher Lp(a) plasma levels, whereas the patients with high-molecular-weight apo(a) isoforms had lower Lp(a) plasma levels. Urinary apo(a) showed a very similar pattern to that of plasma Lp(a), being significantly higher in patients with low-molecular-weight isoforms as compared with patients with high-molecular-weight isoforms. Urinary apo(a) excretion was significantly decreased in the patient group when compared with healthy controls. There was a close correlation (P < 0.001) between the plasma Lp(a) and urinary apo(a) excretion in both the patient group and the control group. Urinary apo(a) excretion did not correlate with protein excretion, creatinine clearance or plasma creatinine levels. We conclude that urinary apo(a) excretion correlates with plasma Lp(a) and Lp(a) isoforms, and that proteinuric patients excrete significantly less apo(a) into their urine than healthy controls, a factor that might contribute to increased plasma Lp(a) levels in these patients.
K M Kostner, and
S Banyai, and
M Banyai, and
G Bodlaj, and
G Maurer, and
K Derfler, and
W H Hörl, and
R Oberbauer
January 2005,
Renal failure,
K M Kostner, and
S Banyai, and
M Banyai, and
G Bodlaj, and
G Maurer, and
K Derfler, and
W H Hörl, and
R Oberbauer
January 2014,
Clinical and experimental rheumatology,
K M Kostner, and
S Banyai, and
M Banyai, and
G Bodlaj, and
G Maurer, and
K Derfler, and
W H Hörl, and
R Oberbauer
December 2015,
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
K M Kostner, and
S Banyai, and
M Banyai, and
G Bodlaj, and
G Maurer, and
K Derfler, and
W H Hörl, and
R Oberbauer
June 1998,
European journal of clinical investigation,
K M Kostner, and
S Banyai, and
M Banyai, and
G Bodlaj, and
G Maurer, and
K Derfler, and
W H Hörl, and
R Oberbauer
January 2011,
Advances in medical sciences,
K M Kostner, and
S Banyai, and
M Banyai, and
G Bodlaj, and
G Maurer, and
K Derfler, and
W H Hörl, and
R Oberbauer
July 1987,
Annals of clinical biochemistry,
K M Kostner, and
S Banyai, and
M Banyai, and
G Bodlaj, and
G Maurer, and
K Derfler, and
W H Hörl, and
R Oberbauer
September 1963,
Clinica chimica acta; international journal of clinical chemistry,
K M Kostner, and
S Banyai, and
M Banyai, and
G Bodlaj, and
G Maurer, and
K Derfler, and
W H Hörl, and
R Oberbauer
May 1972,
Acta medica Scandinavica,
K M Kostner, and
S Banyai, and
M Banyai, and
G Bodlaj, and
G Maurer, and
K Derfler, and
W H Hörl, and
R Oberbauer
January 1993,
Contributions to nephrology,
K M Kostner, and
S Banyai, and
M Banyai, and
G Bodlaj, and
G Maurer, and
K Derfler, and
W H Hörl, and
R Oberbauer
May 2009,
Clinica chimica acta; international journal of clinical chemistry,
